Alan Abdulla
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 32
- Antibiotics Pharmacokinetics and Efficacy 32
- Epidemiology 20
- Pneumonia and Respiratory Infections 17
- Sepsis Diagnosis and Treatment 3
- Co-authors
- Birgit C. P. Koch (32 shared papers)Tim M. J. Ewoldt (18 shared papers)Henrik Endeman (18 shared papers)Anouk E. Muller (16 shared papers)Nicole Hunfeld (13 shared papers)Soma Bahmany (6 shared papers)Teun van Gelder (3 shared papers)Brenda C. M. de Winter (11 shared papers)
- Journals
- Expert Opinion on Drug Metabolism & Toxicology (5 papers)Therapeutic Drug Monitoring (3 papers)Antibiotics (2 papers)BMC Infectious Diseases (2 papers)Clinical Pharmacokinetics (2 papers)
- Partner nations
- NetherlandsBelgiumSwitzerland
In The Last Decade
Alan Abdulla
32 papers receiving 508 citations
Peers
Comparison fields: 5 of 65
- Applied Microbiology and Biotechnology 131
- Molecular Medicine 131
- Pharmacology 436
- Clinical Biochemistry 89
- Epidemiology 226
Countries citing papers authored by Alan Abdulla
This map shows the geographic impact of Alan Abdulla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Abdulla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Abdulla more than expected).
Fields of papers citing papers by Alan Abdulla
This network shows the impact of papers produced by Alan Abdulla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Abdulla. The network helps show where Alan Abdulla may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Abdulla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 90 | |
| 2 | 2020 | 65 | |
| 3 | 2017 | 65 | |
| 4 | 2022 | 60 | |
| 5 | 2021 | 37 | |
| 6 | 2022 | 31 | |
| 7 | 2020 | 26 | |
| 8 | 2021 | 21 | |
| 9 | 2023 | 13 | |
| 10 | 2022 | 12 | |
| 11 | 2023 | 10 | |
| 12 | 2021 | 10 | |
| 13 | 2022 | 8 | |
| 14 | 2022 | 7 | |
| 15 | 2022 | 7 | |
| 16 | 2021 | 6 | |
| 17 | 2015 | 6 | |
| 18 | 2023 | 6 | |
| 19 | 2023 | 5 | |
| 20 | 2022 | 4 |
About Alan Abdulla
Alan Abdulla is a scholar working on Pharmacology, Epidemiology, Molecular Medicine, Pediatrics, Perinatology and Child Health and Applied Microbiology and Biotechnology, having authored 34 papers that have together received 513 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (32 papers), Pneumonia and Respiratory Infections (17 papers), Antibiotic Resistance in Bacteria (10 papers), Antibiotic Use and Resistance (7 papers), Bacterial Identification and Susceptibility Testing (6 papers), Pharmaceutical studies and practices (5 papers), Analytical Methods in Pharmaceuticals (4 papers) and Sepsis Diagnosis and Treatment (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (131 citations), Molecular Medicine (131 citations), Pharmacology (436 citations), Clinical Biochemistry (89 citations) and Epidemiology (226 citations). Alan Abdulla has collaborated with scholars based in Netherlands, Belgium and Switzerland. Frequent co-authors include Birgit C. P. Koch, Tim M. J. Ewoldt, Henrik Endeman, Anouk E. Muller, Nicole Hunfeld, Soma Bahmany, Teun van Gelder, Brenda C. M. de Winter, Diederik Gommers and Annemieke Dijkstra. Their work appears in journals such as Expert Opinion on Drug Metabolism & Toxicology, Therapeutic Drug Monitoring, Antibiotics, BMC Infectious Diseases and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.